INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES
-
![GettyImages-1220710526 lab, research]( "Ease Is How Good Work Happens")
Ease Is How Good Work HappensClinical research teams thrive in the Flow State, where systems align, data connects, and work becomes purposeful, not painful. Ease is clarity, not complexity.
-
![The Future Of AI Analytics]( "Future Of AI Analytics In Chronic Pain And Neurological Research")
Future Of AI Analytics In Chronic Pain And Neurological ResearchThis presentation explores how digital health tools and AI diagnostics are transforming clinical research, driving accurate evaluations and faster therapy development for chronic pain and neurological disorders.
-
![GettyImages-1363170016 wearables]( "Creating Success With Digital Measures")
Creating Success With Digital MeasuresRecent research from the Tufts Center for the Study of Drug Development (CSDD) illuminated the substantial ROI of digital endpoints in clinical trials. Discover how to transform your trials today.
-
![GettyImages-1413600685-laboratory-computer-screen-analysis]( "Revolutionizing Clinical Analytics")
Revolutionizing Clinical AnalyticsIn this 4-part series, learn about AI-driven methods that streamline data mapping and highlight critical issues that allow clinical teams to focus on what truly matters.
-
Pharma R&D Review 2024: Pleasant Weather Ahead5/16/2024
Gain insights from the 2024 pharma landscape, which reports a record-breaking 22,825 pipeline drugs, led by Pfizer's 32 new candidates and a strong focus on oncology and neurological treatments.
-
Patient-Reported Outcome In Oncology Clinical Trials4/17/2025
As cancer therapies grow more complex and personalized, patient-reported outcomes (PROs) have emerged as a vital component of oncology research and care.
-
Cloud vs. On-Premises In The Pharmaceutical Industry3/17/2025
Many pharmaceutical companies are considering implementing cloud solutions to address the growing complexity of traditional clinical trials, fragile supply chains, and increasing regulatory pressures.
-
How Do Site Payments Impact Clinical Trial Sustainability?4/16/2025
Financial stability is critical for trial sites, yet many sites grapple with substantial payment delays. To mitigate these challenges, it's imperative to reassess traditional payment practices,
-
A New, AI-Augmented Horizon For Safety And Pharmacovigilance1/6/2026
Is your organization leveraging AI to maximize efficiency in safety and regulatory workflows? If not, explore how these technologies are slated to improve industry approaches in 2026.
CLINICAL TRIAL TECHNOLOGY SOLUTIONS
-
![GettyImages-1146439597 data, research, tablet]( "RWD & Human Insight From Consulting & Analytics")
Citeline’s Consulting & Analytics team helps clinical trials harness the power of real-world data (RWD) by transforming raw numbers into actionable insights.
-
![Vaccines and syringe in laboratory-GettyImages-1289691489]( "Vaccine Solution")
Explore how this unified vaccine solutions platform integrates advanced tools for vaccine trials, offering unified data management that reduces silos, enabling efficient decision-making.
-
![High speed hi-tech technology-GettyImages-2158132091]( "Data Integrity Drives Every Step Of Your Clinical Trial")
Choose the right Data Sciences team to save time without compromising quality. Find out what sets us apart, from comprehensive strategies to cutting-edge solutions.
-
![GettyImages-484096326_business]( "SmartSignals Streamlines eClinical Workflows")
With robust APIs, detailed guides, and real-time monitoring, Signant SmartSignals Marketplace enhances eClinical workflows, minimizing duplication and ensuring reliable data across systems.
-
![GettyImages-2032712502-scientists-tablet-training-labratory]( "Navigate The Early Phases Of Product Development With Ease")
Early Phase Experts
As a full-service contract research organization, Southern Star Research has the knowledge, industry relationships and technical expertise to get your early-phase clinical trial up and running safely and efficiently.
With a broad range of experience delivering Phase 1 Healthy Volunteer, First in Human, First in Patient and Phase 2 trials, we know just how important it is for your asset to succeed in the early development lifecycle. Our experienced team will help you obtain high-quality data that will appeal to future investors, meet the requirements of international regulatory bodies such as the FDA, EMA, PMDA, and Health Canada, and prepare your product for larger Phase 3 and 4 studies, partnerships, licensing, and sale.
Whatever your clinical trial needs, we can provide a flexible, bespoke solution that will not only meet your regulatory requirements but also position your product for commercial success.
